Clinical

Dataset Information

Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.


ABSTRACT: Interventions: Vaccination using epitope peptide Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616457 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR